Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183


Hospitalization rates before and after adult-to-adult living donor or deceased donor liver transplantation.

Merion RM, Shearon TH, Berg CL, Everhart JE, Abecassis MM, Shaked A, Fisher RA, Trotter JF, Brown RS Jr, Terrault NA, Hayashi PH, Hong JC; A2ALL Study Group..

Ann Surg. 2010 Mar;251(3):542-9. doi: 10.1097/SLA.0b013e3181ccb370.


Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium.

Zimmerman MA, Baker T, Goodrich NP, Freise C, Hong JC, Kumer S, Abt P, Cotterell AH, Samstein B, Everhart JE, Merion RM.

Liver Transpl. 2013 Mar;19(3):259-67. doi: 10.1002/lt.23595.


Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.

Terrault NA, Shiffman ML, Lok AS, Saab S, Tong L, Brown RS Jr, Everson GT, Reddy KR, Fair JH, Kulik LM, Pruett TL, Seeff LB; A2ALL Study Group..

Liver Transpl. 2007 Jan;13(1):122-9.


Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation.

Shaked A, Ghobrial RM, Merion RM, Shearon TH, Emond JC, Fair JH, Fisher RA, Kulik LM, Pruett TL, Terrault NA; A2ALL Study Group..

Am J Transplant. 2009 Feb;9(2):301-8. doi: 10.1111/j.1600-6143.2008.02487.x. Epub 2008 Dec 15.


Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study.

Freise CE, Gillespie BW, Koffron AJ, Lok AS, Pruett TL, Emond JC, Fair JH, Fisher RA, Olthoff KM, Trotter JF, Ghobrial RM, Everhart JE; A2ALL Study Group..

Am J Transplant. 2008 Dec;8(12):2569-79. doi: 10.1111/j.1600-6143.2008.02440.x. Epub 2008 Oct 24.


Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.

Fisher RA, Kulik LM, Freise CE, Lok AS, Shearon TH, Brown RS Jr, Ghobrial RM, Fair JH, Olthoff KM, Kam I, Berg CL; A2ALL Study Group..

Am J Transplant. 2007 Jun;7(6):1601-8.


Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort.

Kulik LM, Fisher RA, Rodrigo DR, Brown RS Jr, Freise CE, Shaked A, Everhart JE, Everson GT, Hong JC, Hayashi PH, Berg CL, Lok AS; A2ALL Study Group..

Am J Transplant. 2012 Nov;12(11):2997-3007. doi: 10.1111/j.1600-6143.2012.04272.x. Epub 2012 Sep 20.


Living-donor or deceased-donor liver transplantation for hepatic carcinoma: a case-matched comparison.

Wan P, Zhang JJ, Li QG, Xu N, Zhang M, Chen XS, Han LZ, Xia Q.

World J Gastroenterol. 2014 Apr 21;20(15):4393-400. doi: 10.3748/wjg.v20.i15.4393.


The Risk of End-Stage Renal Disease Among Living Donor Liver Transplant Recipients in the United States.

Goldberg DS, Ruebner RL, Abt PL.

Am J Transplant. 2015 Oct;15(10):2732-8. doi: 10.1111/ajt.13314. Epub 2015 May 12.


Endoscopic management of biliary complications after adult living-donor versus deceased-donor liver transplantation.

Gómez CM, Dumonceau JM, Marcolongo M, de Santibañes E, Ciardullo M, Pekolj J, Palavecino M, Gadano A, Dávolos J.

Transplantation. 2009 Dec 15;88(11):1280-5. doi: 10.1097/TP.0b013e3181bb48c2.


Live donor liver transplantation: a valid alternative for critically ill patients suffering from acute liver failure.

Goldaracena N, Spetzler VN, Marquez M, Selzner N, Cattral MS, Greig PD, Lilly L, McGilvray ID, Levy GA, Ghanekar A, Renner EL, Grant DR, Selzner M.

Am J Transplant. 2015 Jun;15(6):1591-7. doi: 10.1111/ajt.13203. Epub 2015 Mar 19.


Living donor versus deceased donor liver transplantation: a surgeon-matched comparison of recipient morbidity and outcomes.

Reichman TW, Katchman H, Tanaka T, Greig PD, McGilvray ID, Cattral MS, Renner EL, Selzner M, Ghanekar A, Levy G, Grant DR.

Transpl Int. 2013 Aug;26(8):780-7. doi: 10.1111/tri.12127. Epub 2013 Jun 7.


Comparing living donor and deceased donor liver transplantation: A matched national analysis from 2007 to 2012.

Hoehn RS, Wilson GC, Wima K, Hohmann SF, Midura EF, Woodle ES, Abbott DE, Singhal A, Shah SA.

Liver Transpl. 2014 Nov;20(11):1347-55. doi: 10.1002/lt.23956.


Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients.

Jain A, Venkataramanan R, Sharma R, Kwong T, Orloff M, Abt P, Kashyap R, Tsoulfas G, Batzold P, Williamson M, Bozorgzadeh A.

Transplantation. 2008 Feb 27;85(4):554-60. doi: 10.1097/TP.0b013e3181642c95.


Comparison of the outcomes of patients who underwent deceased-donor or living-donor liver transplantation after successful downstaging therapy.

Lei J, Yan L, Wang W.

Eur J Gastroenterol Hepatol. 2013 Nov;25(11):1340-6. doi: 10.1097/MEG.0b013e3283622743.


Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation.

Vagefi PA, Ascher NL, Freise CE, Dodge JL, Roberts JP.

Liver Transpl. 2012 Feb;18(2):160-5. doi: 10.1002/lt.22455.


Outcomes of patients with benign liver diseases undergoing living donor versus deceased donor liver transplantation.

Li C, Mi K, Wen Tf, Yan Ln, Li B, Yang Jy, Xu Mq, Wang Wt, Wei Yg.

PLoS One. 2011;6(11):e27366. doi: 10.1371/journal.pone.0027366. Epub 2011 Nov 7.


Resource utilization of living donor versus deceased donor liver transplantation is similar at an experienced transplant center.

Lai JC, Pichardo EM, Emond JC, Brown RS Jr.

Am J Transplant. 2009 Mar;9(3):586-91. doi: 10.1111/j.1600-6143.2008.02511.x. Epub 2008 Feb 3.

Supplemental Content

Support Center